Pharmacy Healthy and Information Technology (PHIT) Collaborative Announces New Executive Director Jeff Rochon

1 year ago

ALEXANDRIA, VA / ACCESSWIRE / October 28, 2024 / The Executive Committee of the Pharmacy Health and Information Technology (PHIT)…

CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings

1 year ago

Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the…

MentalHealth.com Launches Mental Health Network

1 year ago

SAN FRANCISCO, CA / ACCESSWIRE / October 28, 2024 / Leading health technology company MentalHealth.com is proud to announce the…

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

1 year ago

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets

1 year ago

Strengthens AI Nose Gas Sensing Technology with Additional Exclusively Licensed PatentsSecures Exclusive Rights to Breakthrough Nitrogen-Oxygen Separation Technology with Superior…

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

1 year ago

LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…

MIRA Pharmaceuticals’ Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain

1 year ago

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at…

IRLAB: Invitation to the Interim Report for Q3 2024 Presentation and Webcast

1 year ago

GOTHENBURG, SWEDEN / ACCESSWIRE / October 28, 2024 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing…

NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements

1 year ago

ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

1 year ago

MARLBOROUGH, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…